Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in mice

Overview of attention for article published in Journal of Neuroinflammation, September 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 1 X user

patent: 2 patents

Readers on

mendeley: 82 Mendeley

So far, Altmetric has seen 1 X post from an account with 361 followers.

$INMB XPro1595 vs TNF inhibitor Adalimumab rec for children over 5 but it prevents ligands from binding to TNFR2, the beneficial pro cell survival receptor unaffected by XPro . Confirmation of XPro‘s mechanism of action in a damaged spinal cord model. htt…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.